Global trends and epidemiology |
[14] |
E. coli, K. pneumoniae
|
- |
Rapid increase in incidence rates of AMR among clinically important pathogens. |
Prevalence and impact of E. coli infections |
[19] |
E. coli
|
ESBLs |
Increasing detection rates of ESBLs among E. coli causing infections in humans. |
K. pneumoniae epidemiology |
[31,34,35] |
K. pneumoniae
|
Carbapenemases, ESBLs |
Widespread resistance to aminoglycosides, carbapenems, quinolones, and polymyxins. |
Phylogenetic background and strain adaptation |
[11,15] |
E. coli
|
- |
Clonal adaptation and increasing prevalence, especially of E. coli ST131, in humans. |
Transmission of AMR via direct/indirect contact |
[37,50,51,52,53] |
E. coli, K. pneumoniae
|
ESBL, KPC-2 |
Increased risk of transmission among dairy farm workers; indirect transmission through food and environment; low evidence of direct transmission. |
Pasteurization and raw milk consumption |
[32,52,55,56] |
E. coli, Enterobacterales
|
ESBL |
Significant variation in raw milk consumption worldwide; association between raw milk and bacterial spread from cows to humans. |
MGEs and AMR spread |
[24,58,59] |
E. coli
|
- |
Emphasis on the role of MGEs in the spread of AMR; inconsistent strain distribution in bovine milk vs. human clinical strains. |
Specific MGEs in mastitis |
[39,60,61,62,63,64,65,66,67,68] |
E. coli, Enterobacterales
|
blaCTX-M, blaCMY-2, blaOXA-181
|
ISEcp1 linked to blaCTX-M genes and their dissemination; chromosomal and plasmid locations noted. |
Plasmids and AMR genes |
[39,76,77,78,79,80,81,82] |
E. coli, K. pneumoniae
|
blaCTX-M, blaTEM, blaSHV, blaCMY
|
High mobility of IncI1, IncN, and IncF plasmids among isolates; widespread dissemination of ESBL genes like blaCTX-M-15.
|
Integrons and gene cassettes |
[60,71,72,73,74,75] |
E. coli, K. pneumoniae
|
Various |
High prevalence of class 1 integrons among isolates; need for full genetic context in epidemiological studies. |
Surveillance and monitoring |
[85,88,89] |
E. coli, Klebsiella spp., other Enterobacteriaceae
|
ESBL/AmpC |
Increasing resistance in E. coli isolates from cattle; presence of ESBL/AmpC producers. |
Antimicrobial stewardship in mastitis |
[90,91,92,95,98,99,100,105] |
E. coli, Klebsiella spp. |
- |
Antimicrobial therapy for mastitis control is not always necessary: spontaneous cure or presence of non-susceptible pathogens. Varied pathogen responses influence treatment choices. Most mild and moderate CM caused by E. coli does not require antimicrobial treatment. |
Environmental stewardship |
[108,112,115,116] |
E. coli, other Enterobacteriaceae
|
- |
Presence of antimicrobial residue and multidrug-resistant E. coli in waste milk fed to calves and flushing wastewater dairy pond effluent as a potential disseminator AMR bacterium when used as soil fertilizer. |